1. Home
  2. DCI vs RGEN Comparison

DCI vs RGEN Comparison

Compare DCI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

HOLD

Current Price

$88.68

Market Cap

10.5B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$164.06

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCI
RGEN
Founded
1915
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
8.2B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
DCI
RGEN
Price
$88.68
$164.06
Analyst Decision
Hold
Buy
Analyst Count
4
10
Target Price
$92.50
$174.90
AVG Volume (30 Days)
777.1K
583.5K
Earning Date
12-04-2025
02-19-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
N/A
EPS
3.21
0.03
Revenue
$3,726,200,000.00
$707,890,000.00
Revenue This Year
$4.61
$17.84
Revenue Next Year
$4.58
$12.44
P/E Ratio
$28.16
$6,546.81
Revenue Growth
2.37
11.74
52 Week Low
$57.45
$102.97
52 Week High
$95.00
$182.52

Technical Indicators

Market Signals
Indicator
DCI
RGEN
Relative Strength Index (RSI) 43.82 53.89
Support Level $90.13 $161.41
Resistance Level $93.52 $167.65
Average True Range (ATR) 1.32 4.48
MACD -0.53 0.01
Stochastic Oscillator 0.72 68.63

Price Performance

Historical Comparison
DCI
RGEN

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: